Safety and efficacy of angiotensin II receptor antagonists

被引:0
|
作者
Neutel, JM [1 ]
机构
[1] Orange Cty Heart Inst, Orange, CA 92668 USA
[2] Res Ctr, Orange, CA USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1999年 / 84卷 / 2A期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A disturbing pattern in the management of hypertension is emerging worldwide. More patients are being treated for hypertension, but blood pressures are not decreasing to target levels. Inadequate reduction in blood pressure is a risk factor for coronary artery disease. Poor drug efficacy, side effects, and lack of compliance are important factors leading to inadequate control of blood pressure. Angiotensin II receptor antagonists provide adequate 24-hour blood pressure control, as measured by ambulatory blood pressure monitoring, and have a side-effect profile similar to placebo. They also provide better patient compliance through once-daily dosing. This article compares the safety and efficacy of angiotensin II receptor antagonists with other antihypertensive agents. (C) 1999 by Excerpta Medica, Inc.
引用
收藏
页码:13K / 17K
页数:5
相关论文
共 50 条
  • [41] Angiotensin II receptor antagonists: are they all the same?
    Mounier-Vehier, C
    Devos, P
    PRESSE MEDICALE, 2001, 30 (21): : 1072 - 1075
  • [42] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    NAKA, T
    KUBO, K
    FURUKAWA, Y
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1995, 53 (09) : 802 - 810
  • [43] DIHYDROPYRIMIDINE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    ATWAL, KS
    AHMED, SZ
    BIRD, JE
    DELANEY, CL
    DICKINSON, KEJ
    FERRARA, FN
    HEDBERG, A
    MILLER, AV
    MORELAND, S
    OREILLY, BC
    SCHAEFFER, TR
    WALDRON, TL
    WELLER, HN
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (25) : 4751 - 4763
  • [44] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    STEINBERG, MI
    WIEST, SA
    PALKOWITZ, AD
    CARDIOVASCULAR DRUG REVIEWS, 1993, 11 (03): : 312 - 358
  • [45] Teratogenicity with angiotensin II receptor antagonists in pregnancy
    Boix, E
    Zapater, P
    Picó, A
    Moreno, O
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (11) : 1029 - 1031
  • [46] Teratogenicity with angiotensin II receptor antagonists in pregnancy
    E. Boix
    P. Zapater
    A. Picó
    O. Moreno
    Journal of Endocrinological Investigation, 2005, 28 : 1029 - 1031
  • [47] Renal effects of angiotensin II receptor antagonists
    Burgess, E
    BLOOD PRESSURE, 2001, 10 : 17 - 20
  • [48] Hypoglycaemia associated with the use of angiotensin II receptor antagonists: A safety signal generated by confounding
    Gregoire, Fleur
    Pariente, Antoine
    Fourrier, Annie
    Haramburu, Francoise
    Moore, Nicholas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S252 - S252
  • [49] Comparative anti hypertensive efficacy of olmesartan: comparison with other angiotensin II receptor antagonists
    Oparil, S
    JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (Suppl 2) : S17 - S23
  • [50] Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan
    Monterroso, VH
    Chavez, VR
    Carbajal, ET
    Vogel, DR
    Martinez, GJA
    Garcia, LH
    Cuevas, JHB
    Teran, JL
    Hitzenberger, G
    Neves, PL
    Middlemost, SJ
    Dumortier, T
    Bunt, AMG
    Smith, RD
    ADVANCES IN THERAPY, 2000, 17 (02) : 117 - 131